Diagnostics

& AI

Artificial intelligence (AI) can be used to help medical professionals to perform diagnoses, by applying innovative algorithms to real-world data obtained from patients. Along with fields such as bioinformatics and digital health, this is an area of technology which is rapidly growing as a result of the development of the underlying core AI and machine learning techniques.

Computer-aided diagnosis can be used alongside (or instead of) more traditional medical techniques in order to help doctors to diagnose a range of conditions without the need for any form of invasive surgery, ultimately greatly improving the efficiency of the diagnostic process. Diagnosis is not the only scenario in which AI and machine learning techniques can be used to provide better results, more quickly: the same techniques can also be applied in order to predict an overall prognosis for a patient, as well as to predict their response to a particular course of treatment. As the amount of available data increases, and more sophisticated algorithms and machine learning models are developed, these tools will become more effective.

Methods of diagnosis performed on the human or animal body, and computer programs are two types of invention which are per se generally excluded from patent protection in the UK and Europe. However, our attorneys at Mewburn Ellis have a deep understanding of the law, and the considerations which apply when patenting inventions in these fields, ensuring that an invention is not dismissed as being a computer program or a method of diagnosis. This detailed knowledge of the law, along with a multi-disciplinary team including attorneys from both our software/computing and life sciences teams means that we are able to maximize our clients’ chances of obtaining patent protection in these fields.

Open pages of Eng Opp Report

Special Report

EPO Opposition Trends in Engineering, Electronics and Software

In autumn 2020, we analysed more than 8000 opposition cases filed at the European Patent Office (EPO) over the last 12 years, studying the timelines for hundreds of engineering, electronics and software oppositions.

The research enabled us to see how oppositions have been affected by procedural changes at the European Patent Office and by the Covid-19 pandemic. With a focus on Transport, Medical Devices, Telecommunications and Software, the report also looks at how opposition outcomes vary across the four different technology sectors and which players are the most active.

Download the Report

Read our Blogs

Most opposed medical device companies at the EPO 2023

Most opposed medical device companies at the EPO 2023

by Tom Furnival

Following on from our recent post on the Most Opposed Companies at the EPO 2023 we’ve broken that data up and looked into a smaller subset, and specifically Medical devices. This has broadly been ...

How could NASA tech benefit postmenopausal women?

How could NASA tech benefit postmenopausal women?

by Charlotte Lynch

Over 14,000 postmenopausal women in England may benefit from the recent approval of new osteoporosis drug abaloparatide by the National Institute for Health and Care Excellence (1,2).

Polycystic Ovary Syndrome awareness month

Polycystic Ovary Syndrome awareness month

by Frances Salisbury

September is PCOS awareness month. PCOS, which stands for Polycystic Ovary Syndrome, is a hormonal condition that affects between 6 and 20% of reproductive age women. It can cause a wide range of ...

The Science of Success: Optimising Female Athletic Performance

The Science of Success: Optimising Female Athletic Performance

by Sarah Harvey

For the first time in Olympic history, the Paris 2024 Games achieved gender parity among athletes. Female competitors delivered many of the most memorable moments, while off the track, an increasing ...

Navigating the Dual Pathways: Regulatory Approval and Patent Protection for Medical Devices

Navigating the Dual Pathways: Regulatory Approval and Patent Protection for Medical Devices

by Joe Egelstaff

For medical device manufacturers and designers, the journey to market success hinges on two crucial milestones: securing regulatory approval and obtaining patent protection. While these processes ...

The HPV vaccine: the global success of prioritising women’s health

The HPV vaccine: the global success of prioritising women’s health

by Charlotte Lynch

Let's talk about the HPV vaccine - a revolutionary drug and global strategy that proved how investing in and raising awareness about women's health benefits everyone.

Learn More
Forward Magazines Overlapping 8

Mewburn Ellis

FORWARD MAGAZINE

Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.